-
-
-
-
-
-
-
ENHERTU plus pertuzumab approved for first-line HER2+ metastatic breast cancer
-
-
-
-
-
-
-
Daiichi Sankyo Company, Limited (4568:JP) (DSNKY) PT Raised to JPY7,600 at Jefferies
-
-
489,217 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


